...Operator Good morning. My name is Melissa, and I will serve as your conference call operator. (Operator Instructions) As a reminder, this conference is being recorded. Joining me on the call today will be Dr. Pete Salzmann, Chief Executive Officer of Immunovant. Before we begin, I would like to remind everyone that today's conference call will include certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, for example, statements regarding potential efficacy and safety of Immunovant's product candidates; and Immunovant's expectations regarding the timing, design and results of its clinical trials, including the timing of future readouts and data readouts and the announcement of future indications. These forward-looking statements are not guarantees of future performance; and are subject to risks and uncertainties, assumptions known or unknown which could cause actual results to vary materially...